[go: up one dir, main page]
Wikidata

(Q61868247)

English

European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma

scientific article published in January 2000

In more languages
default for all languages
No label defined

No description defined

Statements

title
European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma (English)
0 references
author name string
J M Foran
series ordinal
1
0 references
A Z Rohatiner
series ordinal
2
0 references
R A Popescu
series ordinal
4
0 references
P Solal-Celigny
series ordinal
5
0 references
M Ghielmini
series ordinal
6
0 references
B Coiffier
series ordinal
7
0 references
P W Johnson
series ordinal
8
0 references
C Gisselbrecht
series ordinal
9
0 references
F Reyes
series ordinal
10
0 references
J A Radford
series ordinal
11
0 references
E M Bessell
series ordinal
12
0 references
B Souleau
series ordinal
13
0 references
A Benzohra
series ordinal
14
0 references
T A Lister
series ordinal
15
0 references
publication date
January 2000
0 references
volume
18
0 references
issue
2
0 references
page(s)
317-24
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61868247&oldid=2116193450"